ClinicalTrials.gg
RecruitingNCT06183463Repair-SMUpdated Dec 27, 2023

The Use of Reconstructive Surgery for Sexually Mutilated Women at the University Hospitals of Strasbourg

An observational study in Sexual Trauma, sponsored by University Hospital, Strasbourg, France. Recruiting at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-12-27.

Sponsored by University Hospital, Strasbourg, France · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2023, 2 years 11 months ago, but the record still lists the study as recruiting.
  • Started Nov 2022; still recruiting 3 years 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
29
Ages
18 Years and older
Sex
Female
01

Study summary

Despite awareness since the 1980s and a legal framework to punish sexual mutilation, this tradition continues in many countries, particularly in Africa but not only in the Middle East, Malaysia and Indonesia. This custom, carried out among increasingly young little girls, exposes them to infectious, hemorrhagic and even death risks and sometimes significant obstetric complications.

Every year, 3 million girls and young women are sexually mutilated around the world, or one woman every 15 seconds.

In recent years, a surgical repair technique has been created by a French urologist, Professor Foldès. This technique allows clitoral reconstruction. Sensory reacquisition after this intervention may take a few months, but the functional results are quite good.

There is little or no data concerning the use of reconstructive surgery for these mutilated patients consulting in sexology and the future of patients post-operatively or who have not had recourse to reconstructive surgery. The investigators then questioned the decision of these patients and their future.

02

Conditions studied

  • Sexual Trauma

Browse trials for

Keywords

  • Sexual mutilation
03

In context

Sexual Trauma

14 studies on the registry are indexed under Sexual Trauma; 6 are open to participants now.

Browse Sexual Trauma studies →

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 1,000 studies on the registry; 359 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult woman (≥18 years old) having consulted sexology at the HUS for sexual mutilation between 01/01/2011 and 12/31/2021.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult woman (≥18 years old)
  • having consulted sexology at the HUS for sexual mutilation between 01/01/2011 and 12/31/2021.
  • having had clitoral repair surgery at the HUS between 01/01/2011 and 12/31/2021
  • not objecting, after information, to the reuse of their data for the purposes of this research

Exclusion criteria

Exclusion Criteria:

  • Woman who expressed her opposition to participating in the study
  • impossibility of providing the subject with informed information (difficulties in understanding the subject, etc.)
  • Woman under judicial protection or under guardianship or curatorship.
05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
29 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Evaluation of the future of patients who consulted sexology for sexual mutilation between 2011 and 2021 at the HUS, whether or not they opted for reconstructive surgery.

    This assessment is made via a questionnaire of nine questions relating to their future.

    Time frame: Through study completion, an average of 6 months

07

Study locations

1 of 1 sites recruiting
  • Service d'Assistance Médicale à la Procréation - CHU de Strasbourg - France
    Strasbourg, 67091, France
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Nov 2022 (actual). Primary completion is estimated for Dec 2023, 13 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 13, 2023
First posted
Dec 27, 2023
StartActual
Nov 24, 2022
Primary completionEst.
Dec 2023
CompletionEst.
Dec 2023
Last update
Dec 27, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 27, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06183463
Responsible party
Sponsor
First posted
Dec 27, 2023
Start date
Nov 24, 2022
Primary completion
Dec 2023 (estimated)
Completion
Dec 2023 (estimated)
Last update
Dec 27, 2023

Study contacts

Jeanine OHL, MD
Contact
jeanine.ohl@chru-strasbourg.fr
33 3 69 55 34 49

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion